{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-038544","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2024-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.236472+00:00","generated_at":"2026-05-31T01:18:52.341997+00:00","sec_items":["3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Mangoceuticals sells 250 Series B Preferred shares for $250,000 in fourth closing under SPA","bullets":["Sold 250 Series B Preferred shares to institutional accredited investor for $250,000; effective price at 10% discount to $1,100 stated value.","Total 750 of 1,000 possible Series B shares sold to date; 250 remain available for future sale.","Full conversion at $0.15 floor price yields 1,833,333 common shares; shareholder approval obtained for >19.99% issuance.","Issuance exempt from registration under Section 4(a)(2) and Rule 506 of Regulation D."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-038544","json":"https://secwatch.observer/filing/0001493152-24-038544.json","markdown":"https://secwatch.observer/filing/0001493152-24-038544.md","text":"https://secwatch.observer/filing/0001493152-24-038544.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000149315224038544/0001493152-24-038544-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000149315224038544/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T01:18:52.341997+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}